Jones JL, Holland GN, 2010. Annual burden of ocular toxoplasmosis in the U.S. Am J Trop Med Hyg 82: 464–465.
Jones JL, Roberts JM, 2012. Toxoplasmosis hospitalizations in the United States, 2008, and trends, 1993–2008. Clin Infect Dis 54: e58–e61.
Lopez A, Dietz V, Wilson M, Navin TR, Jones JL, 2000. Preventing congenital toxoplasmosis. MMWR Recomm Rep 49: 37–75.
Torrey EF, Bartko JJ, Lun ZR, Yolken RH, 2007. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 33: 729–736.
Torrey EF, Bartko JB, Yolken RH, 2012. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 38: 642–647.
Pearce BD, Kruszon-Moran D, Jones JL, 2012. The relationship between Toxoplasma gondii infection and mood disorders in the third national health and nutrition survey. Biol Psychiatry 72: 290–295.
Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, Balis T, Cabassa JA, Scrandis DA, Tonelli LH, Postolache TT, 2009. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 197: 905–908.
Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT, 2012. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psych 69: 1123–1130.
Jones JL, Kruzon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB, 2001. Toxoplasma gondii in the United States, seroprevalence and risk factors. Am J Epidemiol 154: 357–365.
Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M, 2007. Toxoplasma gondii infection in the United States, 1999–2004, decline from the prior decade. Am J Trop Med Hyg 77: 405–410.
Curtin LR, Mohadjer LK, Dohrmann SM, Kruszan-Moran D, Mirel LB, Carroll MD, Hirsch R, Burt VL, Johnson CL, 2013. National Health and Nutrition Examination Survey: Sample design, 2007–2010. National Center for Health Statistics. Vital Health Stat 2 (160). http://www.cdc.gov/nchs/data/series/sr_02/sr02_160.pdf. Accessed January 2, 2014.
Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J, 2013. National Health and Nutrition Examination Survey: Plan and operations, 1999–2010. National Center for Health Statistics. Vital Health Stat 1 (56). Available at: http://www.cdc.gov/nchs/data/series/sr_01/sr01_056.pdf. Accessed January 2, 2014.
U.S. Department of Health and Human Services, 2013. Poverty Guidelines, Research, and Measurement. U.S. Department of Health and Human Services website. Available at: http://aspe.hhs.gov/POVERTY/index.shtml. Accessed January 2, 2014.
Pappas G, Roussos N, Falagas ME, 2009. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39: 1385–1394.
Caballero-Ortega H, Uribe-Salas FJ, Conde-Glez CJ, Cedillo-Pelaez C, Vargas-Villavicencio JA, Luna-Pastén H, Cañedo-Solares I, Ortiz-Alegría LB, Correa D, 2012. Seroprevalence and national distribution of human toxoplasmosis in Mexico: analysis of the 2000 and 2006 National Health Surveys. Trans R Soc Trop Med Hyg 106: 653–659.
Centers for Disease Control and Prevention, 2013. NHANES File Documentation. Available at: http://www.cdc.gov/nchs/nhanes/about_nhanes.htm. Accessed January 2, 2014.
Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszan-Moran D, Dohrmann SM, Curtin LR, 2013. National Health and Nutrition Examination Survey: Analytic guidelines, 1999–2010. National Center for Health Statistics. Vital Health Stat 2 (161). http://www.cdc.gov/nchs/data/series/sr_02/sr02_161.pdf. Accessed January 2, 2014.
Research Triangle Institute, 2012. SUDAAN user's manual release 10.1. Research Triangle Park, NC: Research Triangle Institute.
Jones JL, Dubey JP, 2012. Foodborne toxoplasmosis. Clin Infect Dis 55: 845–851.
Centers for Disease Control and Prevention, 2013. Parasites – Toxoplasmosis. Available at: http://www.cdc.gov/parasites/toxoplasmosis/. Accessed January 2, 2014.
U.S. Pet Ownership & Demographics Sourcebook, 2012. American Veterinary Medical Association. Available at: https://www.avma.org/KB/Resources/Statistics/Pages/Market-research-statistics-US-pet-ownership.aspx. Accessed January 2, 2014.
Hill DE, Coss C, Dubey JP, Wroblewski K, Sautter M, Hosten T, Muñoz-Zanzi C, Mui E, Withers S, Boyer K, Hermes G, Coyne J, Jagdis F, Burnett A, McLeod P, Morton H, Robinson D, McLeod R, 2011. Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol 97: 328–337.
Boyer K, Hill D, Mui E, Wroblewski K, Karrison T, Dubey JP, Sautter M, Noble AG, Withers S, Swisher C, Heydemann P, Hosten T, Babiarz J, Lee D, Meier P, McLeod R, 2011. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis 53: 1081–1089.
Hill DE, Dubey JP, 2013. Toxoplasma gondii prevalence in farm animals in the United States. Int J Parasitol 43: 107–113.
Kotula AW, Dubey JP, Sharar AK, Andrews CD, Shen SK, Lindsay DS, 1991. Effect of freezing on infectivity of Toxoplasma gondii tissue cysts in pork. J Food Prot 54: 687–690.
Hill DE, Sreekumar C, Gamble HR, Dubey JP, 2004. Effect of commonly used enhancement solutions on the viability of Toxoplasma gondii tissue cysts in pork loin. J Food Prot 67: 2230–2233.
McLeod R, Boyer KM, Lee D, Mui E, Wroblewski K, Karrison T, Noble AG, Withers S, Swisher CN, Heydemann PT, Sautter M, Babiarz J, Rabiah P, Meier P, Grigg ME, 2012. Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981–2009). Clin Infect Dis 54: 1595–1605.
|Past two years||Past Year||Past 30 Days|
|Full Text Views||656||302||8|
Toxoplasma gondii is a ubiquitous parasite that can cause neurologic and ocular disease. We tested sera from 7,072 people ≥ 6 years of age in the 2009–2010 National Health and Nutrition Examination Survey (NHANES) for immunoglobulin G antibodies and compared these results with two previous NHANES studies. The overall T. gondii antibody seroprevalence among persons ≥ 6 years of age in 2009–2010 was 13.2% (95% confidence limit [CL] 11.8%, 14.5%) and age-adjusted seroprevalence was 12.4% (95% CL 11.1%, 13.7%); age-adjusted seroprevalence among women 15–44 years of age was 9.1% (95% CL 7.2%, 11.1%). In U.S. born persons 12–49 years of age, the age-adjusted T. gondii seroprevalence decreased from 14.1% (95% CL 12.7%, 15.5%) in NHANES III (1988–1994) to 9.0% (95% CL 7.6%, 10.5%) in NHANES 1999–2004 to 6.7% (95% CL 5.3%, 8.2%) in NHANES 2009–2010 (P < 0.001 linear trend). Although T. gondii antibody presence is still relatively common, the prevalence in the United States has continued to decline.
Authors' addresses: Jeffrey L. Jones, Hilda Rivera, Courtney Price, and Patricia P. Wilkins, Parasitic Diseases Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, E-mails: email@example.com, firstname.lastname@example.org, email@example.com, and firstname.lastname@example.org. Deanna Kruszon-Moran, Division of Health and Nutrition Examination Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD, E-mail: email@example.com.